FDA Approves VP-102 for Molluscum Contagiosum
The long-awaited approval for VP-102 makes this treatment the first available therapy for the pox virus-borne skin disease.
United States Ted White Drug Administration Verrica Pharmaceuticals Announces Verrica Pharmaceuticals American Academy Of Dermatology
Source: hcplive.com